{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:42:49Z","timestamp":1773679369400,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neulet.2021.136420","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T11:04:37Z","timestamp":1640343877000},"page":"136420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian rat"],"prefix":"10.1016","volume":"770","author":[{"given":"Ana","family":"Virel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarkko","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelene","family":"Ericsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger","family":"Laterveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"\u00d6gren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greger","family":"Or\u00e4dd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Jakobson Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"af Bjerk\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neulet.2021.136420_b0005","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1474-4422(06)70549-X","article-title":"The mystery of motor asymmetry in Parkinson's disease","volume":"5","author":"Djaldetti","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2021.136420_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","article-title":"Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification","volume":"298","author":"Blesa","year":"2017","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2021.136420_b0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cne.1098","article-title":"Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: Evidence for interhemispheric functional coupling of the two nigrostriatal pathways","volume":"432","author":"Roedter","year":"2001","journal-title":"Journal of Comparative Neurology."},{"issue":"1","key":"10.1016\/j.neulet.2021.136420_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2011.09.013","article-title":"The interhemispheric connections of the striatum: implications for Parkinson\u2019s disease and drug-induced dyskinesias","volume":"87","author":"Lieu","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.neulet.2021.136420_b0025","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0306-4522(83)90276-2","article-title":"Behavioral and neuronal reorganization after unilateral substantia nigra lesions: Evidence for increased interhemispheric nigrostriatal projections","volume":"9","author":"Pritzel","year":"1983","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neulet.2021.136420_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(81)90072-0","article-title":"Evidence for a crossed nigrostriatal pathway in rats","volume":"22","author":"Fass","year":"1981","journal-title":"Neurosci. Lett."},{"issue":"4315","key":"10.1016\/j.neulet.2021.136420_b0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.910137","article-title":"Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat","volume":"198","author":"Nieoullon","year":"1977","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.neulet.2021.136420_b0040","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1073\/pnas.1603629113","article-title":"Cross-hemispheric dopamine projections have functional significance","volume":"113","author":"Fox","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2021.136420_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: A guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2021.136420_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice","volume":"5","author":"Clark","year":"2010","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.neulet.2021.136420_b0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2012.03.021","article-title":"N-acetyl-cysteine in the treatment of Parkinson\u2019s disease. What are we waiting for?","volume":"79","author":"Mart\u00ednez-Banaclocha","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neulet.2021.136420_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2016.02.010","article-title":"Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo","volume":"296","author":"Nouraei","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.neulet.2021.136420_b0065","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/sj.npp.1300512","article-title":"Protective Effects of N-acetyl-L-cysteine on the Reduction of Dopamine Transporters in the Striatum of Monkeys Treated with Methamphetamine","volume":"29","author":"Hashimoto","year":"2004","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.neulet.2021.136420_b9000","article-title":"N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease","author":"Monti","year":"201611","journal-title":"Preliminary Clinical and Cell Line Data. PloS one"},{"issue":"5","key":"10.1016\/j.neulet.2021.136420_b0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/cpt.1709","article-title":"Potential Role of N-Acetyl-Cysteine in the Cysteine Proteome in Parkinson's Disease?","volume":"107","author":"Martinez\u2010Banaclocha","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2021.136420_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mcn.2019.06.003","article-title":"(1)H NMR profiling of the 6-OHDA parkinsonian rat brain reveals metabolic alterations and signs of recovery after N-acetylcysteine treatment","volume":"98","author":"Virel","year":"2019","journal-title":"Mol Cell Neurosci."},{"issue":"16","key":"10.1016\/j.neulet.2021.136420_b0085","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1016\/j.bmcl.2009.06.032","article-title":"Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter","volume":"19","author":"Schou","year":"2009","journal-title":"Bioorg Med Chem Lett."},{"issue":"1","key":"10.1016\/j.neulet.2021.136420_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-018-0450-0","article-title":"Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT-a clinical comparison","volume":"8","author":"Jakobson Mo","year":"2018","journal-title":"EJNMMI Res."},{"issue":"2","key":"10.1016\/j.neulet.2021.136420_b0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.nucmedbio.2015.11.002","article-title":"PET imaging of dopamine transporters with [18F]FE-PE2I: Effects of anti-Parkinsonian drugs","volume":"43","author":"Bang","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neulet.2021.136420_b0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuroimage.2014.12.080","article-title":"Waxholm Space atlas of the rat brain hippocampal region: Three-dimensional delineations based on magnetic resonance and diffusion tensor imaging","volume":"108","author":"Kjonigsen","year":"2015","journal-title":"NeuroImage."},{"issue":"1","key":"10.1016\/j.neulet.2021.136420_b0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/nimg.1998.0366","article-title":"Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I","volume":"9","author":"Hall","year":"1999","journal-title":"NeuroImage."},{"issue":"9","key":"10.1016\/j.neulet.2021.136420_b0110","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/01.WCB.0000085441.37552.CA","article-title":"Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain","volume":"23","author":"Ichise","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"10.1016\/j.neulet.2021.136420_b0115","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.neulet.2021.136420_b0120","article-title":"Dynamic control of the dopamine transporter in neurotransmission and homeostasis. npj","volume":"7","author":"Bu","year":"2021","journal-title":"Parkinson's Disease."},{"issue":"7","key":"10.1016\/j.neulet.2021.136420_b0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radical Res."},{"issue":"5","key":"10.1016\/j.neulet.2021.136420_b0130","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1046\/j.1460-9568.2003.02800.x","article-title":"Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat","volume":"18","author":"Stanic","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neulet.2021.136420_b0135","first-page":"447","article-title":"Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease","volume":"32","author":"Schlachetzki","year":"2014","journal-title":"Restor Neurol Neuros."},{"issue":"1","key":"10.1016\/j.neulet.2021.136420_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1471-4159.2009.05904.x","article-title":"Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson\u2019s: an in vivo imaging study","volume":"109","author":"Sossi","year":"2009","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neulet.2021.136420_b0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jnr.1149","article-title":"Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism","volume":"65","author":"Rothblat","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.neulet.2021.136420_b0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.21204","article-title":"Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study","volume":"62","author":"Sossi","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2021.136420_b9005","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awn085","article-title":"Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia","volume":"131","author":"Lee","year":"2008","journal-title":"Brain."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021007990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021007990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:41:36Z","timestamp":1759624896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021007990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":31,"alternative-id":["S0304394021007990"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136420","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian rat","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"136420"}}